| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.7B | $10.1B | $9.7B | $9.0B | $8.5B | $1.9B | $2.0B | $0.9B |
| Cost of Revenue | $2.1B | $3.8B | $3.7B | $3.8B | $3.8B | $3.7B | $2.1B | $1.1B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $4.1B | $4.3B | $4.1B | $3.5B | $3.4B | $2.9B | $2.0B | $1.5B |
| Operating Income | $1.8B | $2.3B | $1.7B | $0.6B | $1.4B | $0.3B | $0.2B | $0.2B |
| Net Income | $1.4B | $1.6B | $1.0B | $0.1B | $1.0B | $0.2B | $0.1B | $0.1B |
| EPS (Basic) | $5.79 | $6.18 | $3.78 | $0.41 | $3.30 | $0.61 | $0.34 | $0.48 |
| EPS (Diluted) | $5.78 | $6.16 | $3.77 | $0.40 | $3.29 | $0.61 | $0.34 | $0.47 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $53.3B | $46.9B | $50.6B | $44.8B | $45.3B | $44.2B | $44.5B | $13.2B |
| Current Assets | $12.6B | $6.0B | $8.1B | $6.3B | $4.7B | $4.6B | $4.4B | $3.4B |
| Cash & Equivalents | $8.3B | $2.5B | $2.1B | $2.0B | $2.0B | $1.9B | $1.7B | $1.2B |
| Total Liabilities | $29.6B | $23.9B | $26.8B | $22.3B | $19.4B | $16.7B | $16.4B | $9.0B |
| Current Liabilities | $7.5B | $6.3B | $8.1B | $6.9B | $4.5B | $4.5B | $3.6B | $3.3B |
| Stockholders' Equity | $22.9B | $22.3B | $23.0B | $22.3B | $25.6B | $27.3B | $27.9B | $4.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.7B | $3.5B | $2.2B | $2.2B | $2.8B | $2.3B | $1.4B | $1.1B |
| Investing Cash Flow | $-0.2B | $-0.2B | $-4.4B | $-0.7B | $-2.3B | $-0.4B | $-0.9B | $-1.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $3.7B | $-2.8B | $2.1B | $-1.4B | $-0.4B | $-1.5B | $-0.0B | $0.3B |